Locations:
Cleveland Clinic has expanded its international presence in recent years by opening a new 184-bed hospital in London, as well as other outpatient facilities in the U.K., Toronto, and Abu Dhabi.
Sherman Prize recipients are high performers from a variety of professional disciplines who represent “Excellence in Crohn’s and Colitis” in their chosen endeavors, having dedicated their careers to the fight to overcome IBD.
For the second straight year, Dr. Vince has been recognized by Becker's Healthcare as one of the top 35 chief innovation officers to know.
XR90 is intended to be used adjunctively for minimally invasive ultrasound and CT-guided needle-based procedures for soft tissue and bone.
VisionAir Solutions creates patient-specific airway stents with its 3D-design platform.
Proven technology in 700 patients granted Breakthrough Device designation from the FDA.
Margot Damaser, PhD, Cleveland Clinic Lerner Research Institute, shares her inventor journey.
Cleveland Clinic Innovations team members from Ventures, Engagement, and Business Development & Licensing attend this year's HLTH conference in Las Vegas.
Stanley Hazen, MD, PhD, founder of Zehna Therapeutics, a Cleveland Clinic Innovations portfolio company has been focusing on the relationship between heart and metabolic health for much of his 25 years at Cleveland Clinic. Inhibitors that target gut microbial enzymes are likely the key to treating a variety of cardiovascular diseases, some of which have no other cure.
Health system venture fund leaders discussed their investment strategy, how it changed during the pandemic, and their plans for the post-PHE era.
Search